Alar Pharmaceuticals, Inc. engages in the development of long-acting release drug products for CNS disorders and chronic diseases. It develops drugs for opioid use disorder, chronic pain, and major depressive disorder. The company was founded on September 23, 2016 and is headquartered in Taichung, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company